ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
SAN FRANCISCO — The interventional answer to heavily calcified coronary lesions could reside in a balloon catheter that blasts calcifications with bursts of acoustic energy, suggests an early-stage ...
Boston Scientific drove the cardiovascular space into a frenzy on Friday when it was announced it was rumored to acquire Shockwave Medical, according to a report from Bloomberg citing people with ...
SANTA CLARA, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
Valve Performance of Self-Expanding vs. Balloon-Expandable TAVR in Patients with a Small Aortic Annulus: Five-Year Results From the OCEAN-TAVI Registry Receive the the latest news, research, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results